Table 1 Baseline characteristics of two groups of SLE patients with high score and low score
From: QT dispersion in patients with systemic lupus erythematosus: the impact of disease activity
Variable | High score group (n = 54) | Low score group (n = 50) |
|---|---|---|
Age (years) | 33.88 ± 11.34 | 35.32 ± 10.8 |
Sex (Male:Female) | 3: 51 | 6: 44 |
BMI(kg/m2) | 23.36 ± 4.69 | 24 ± 4.34 |
Systolic blood pressure(mmhg) | 116.48 ± 12.76 | 117.60 ± 9.38 |
Diastolic blood pressure(mmhg) | 77.87 ± 8.4 | 79.20 ± 5.2 |
Duration of disease(year) | 6.64 ± 3.96 | 5.2 ± 3.87 |
Left ventricular ejection fraction | 64.32 ± 11.15 | 65.83 ± 9.75 |
Hydroxychloroquine | 44(42%) | 37(34%) |
Prednisolone | 52(50%) | 43(41%) |
Cytotoxic drugs | 18(17.3%) | 14(13.5%) |
Systemic Lupus Erythematous Disease Activity Index (SLEDAI) | 54(51.92%) | 50(48.07) |